<http://webisa.webdatacommons.org/prov/298410824>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/307364914> .
<http://webisa.webdatacommons.org/307364914>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<freepatentsonline.com> .
<http://webisa.webdatacommons.org/prov/456164181>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/307364914> .
<http://webisa.webdatacommons.org/prov/228390541>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/307364914> .
<http://webisa.webdatacommons.org/307364914>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/5938713>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/307364914> .
<http://webisa.webdatacommons.org/307364914>	<http://www.w3.org/ns/prov#value>	"FIELD OF THE INVENTIONThe present invention relates generally to the field of healing and treatment of wounds, burns, tumors and other skin diseases and disorders, and relates in particular to the direct delivery into skin cells of a genetic construct that encodes a polypeptide having epidermal growth factor activity, and the subsequent secretion of the polypeptide into wound fluid for improved he" .